Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors

NCT07529431 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Cancer-related Fatigue

Interventions

DEVICE: Participants will self-administer transcutaneous vagus nerve stimulation (tVNS) at home using a non-invasive auricular stimulation device for 60 minutes per day over a 6-week period. Participants will

Sponsor

University of Vermont Medical Center